HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme.

AbstractBACKGROUND:
Glioblastoma multiforme (GBM) is a hypervascularized and locally infiltrating brain tumor of astroglial origin with a very poor prognosis. An X-linked c-fos oncogene-inducible mitogenic, morphogenic, and angiogenic factor, endothelial growth factor-D (VEGF-D), is the newest mammalian member of VEGF family. We analyzed VEGF-D in GBM because of its high angiogenic potential and its linkage to the X chromosome.
MATERIALS AND METHODS:
Nonmalignant brain and GBM tissue sections as well as GBM cell lines were analyzed by immunofluorescence for the expression of VEGF-D, factor VIII (endothelial cell marker), glial-fibrillary acidic protein (GFAP) (astrocytic cell lineage cytoplasmic marker), and several Fos family transcription factors, including c-Fos and Fra-1. The proteins were also detected by Western blots. The differences between genotypes of normal brain and GBM cells were examined by cDNA microarrays.
RESULTS AND CONCLUSIONS:
GBM expressed ubiquitously VEGF-D, which colocalized with GFAP. Contrary to our expectations, low levels of c-Fos were detected in GBM cells. However, we identified another Fos family member, Fra-1, together with its transcriptional activation partner, c-Jun, as being stably up-regulated in GBM cells. Furthermore, we demonstrated that a fra-1 transgene induced VEGF-D expression in cultured cells and GBM cell stimulation evoked a sustained increase in both Fra-1 and VEGF-D levels. This study reveals that an up-regulation of AP-1 factors may be a hallmark of GBM. Because VEGF-D activates VEGF receptor 2 and 3, receptors important for tumor angiogenesis, it may represent an X-linked/AP-1-regulated onco-angiogen in human GBM. The VEGF-D system and AP-1 activity appear to be very attractive targets for new molecular diagnostics and rational molecular anti-cancer therapies.
AuthorsW Debinski, B Slagle-Webb, M G Achen, S A Stacker, E Tulchinsky, G Y Gillespie, D M Gibo
JournalMolecular medicine (Cambridge, Mass.) (Mol Med) Vol. 7 Issue 9 Pg. 598-608 (Sep 2001) ISSN: 1076-1551 [Print] England
PMID11778649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelial Growth Factors
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • Transcription Factor AP-1
  • Vascular Endothelial Growth Factor D
  • fos-related antigen 1
Topics
  • Animals
  • Brain (metabolism, pathology)
  • Endothelial Growth Factors (genetics, metabolism)
  • Genetic Linkage
  • Glioblastoma (blood supply, genetics, metabolism, pathology)
  • Humans
  • Immunohistochemistry
  • Mice
  • Neovascularization, Pathologic
  • Proto-Oncogene Proteins c-fos (genetics, metabolism)
  • Proto-Oncogene Proteins c-jun (genetics, metabolism)
  • Transcription Factor AP-1 (metabolism)
  • Tumor Cells, Cultured
  • Vascular Endothelial Growth Factor D
  • X Chromosome (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: